A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Quantifying Disease Pathology and Predicting Diseaffse Progression in Multiple Sclerosis with only Clinical Routine T2-FLAIR MRI
2021
NeuroImage: Clinical
Although quantitative measures from research-quality MRI provide a means to study multiple sclerosis (MS) pathology in vivo, these metrics are often unavailable in legacy clinical datasets. To determine how well an automatically-generated quantitative snapshot of brain pathology, measured only on clinical routine T2-FLAIR MRI, can substitute for more conventional measures on research MRI in terms of capturing multi-factorial disease pathology and providing similar clinical relevance. MRI with
doi:10.1016/j.nicl.2021.102705
pmid:34091352
fatcat:cxh56kcd5jd23azw7u73g5agru